Publication & Citation Trends
Publications
0 total
Addressing unmet needs in relapsed/refractory multiple myeloma: an Italian Delphi consensus on current challenges and emerging therapies
Cited by 0
Semantic Scholar
Pomalidomide, bortezomib and dexamethasone in multiple myeloma refractory to lenalidomide and anti-CD38 monoclonal antibodies: outcomes from a real-world experience
Cited by 0
Semantic Scholar
Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab‐, Elotuzumab‐, and Carfilzomib‐Based Triplet Regimens: A Multicenter Real‐World Analysis of 635 Patients OA
Cited by 1
Semantic Scholar
Correction to: Continous or fixed carfilzomib, lenalidomide and dexamethasone (KRD) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life survey from European myeloma network (EMN) Italy
Cited by 0
Semantic Scholar
Targeting RNA polymerase I to boost natural killer cell anticancer activity in multiple myeloma
Cited by 0
Semantic Scholar
Clinicians' Perspectives and Methodological Application of Fluorescence in situ Hybridization (FISH) to Define Cytogenetic Risk in Multiple Myeloma: An Italian, Real-World, Survey-Based Report From the European Myeloma Network (EMN) Italy.
Cited by 4
Semantic Scholar
Research Topics
Multiple Myeloma Research and Treatments
(277)
Protein Degradation and Inhibitors
(99)
Immune Cell Function and Interaction
(77)
Cancer Treatment and Pharmacology
(54)
Peptidase Inhibition and Analysis
(50)
Affiliations
Università Cattolica del Sacro Cuore
Roma Tre University
University of Salento
Università Campus Bio-Medico
University of Milan